Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action
- 1 March 1997
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 15 (1) , 77-86
- https://doi.org/10.1023/a:1005774713202
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Inhibition of Angiogenesis by Somatostatin and Somatostatin-like Compounds Is Structurally DependentJournal of Surgical Research, 1993
- Somatostatin Analogue Phase I Trials in Neuroendocrine NeoplasmsActa Oncologica, 1993
- Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancyDisease-a-Month, 1991
- Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membraneJournal of Surgical Research, 1991
- Octreotide acetate induces fasting small bowel motility in patients with dumping syndromeJournal of Surgical Research, 1990
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990
- Effect of octreotide acetate on pancreatic exocrine functionThe American Journal of Surgery, 1989
- Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cellsBiochemical and Biophysical Research Communications, 1988
- Somatostatin: A peptide with unexpected physiologic activitiesThe American Journal of Medicine, 1986
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974